| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.04 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.04 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |